04:39 PM EDT, 10/04/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) filed a registration statement Friday with the US Securities and Exchange Commission covering the potential sale of up to $100 million of its securities from time to time in one or more offerings.

The filing covers common and preferred stock, warrants, debt securities, depositary shares, stock purchase contracts, subscription rights and units.

Plus Therapeutics ( PSTV ) said it intends to use the net proceeds from the offering for general corporate purposes.